Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia

BACKGROUND: End-induction minimal residual disease (MRD) is the strongest predictor of relapse in paediatric acute lymphoblastic leukaemia (ALL), but an understanding of the biological pathways underlying early treatment response remains elusive. We hypothesized that metabolomic profiling of diagnos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:EBioMedicine
Autores principales: Schraw, Jeremy M., Junco, Jacob J., Brown, Austin L., Scheurer, Michael E., Rabin, Karen R., Lupo, Philip J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6838385/
https://ncbi.nlm.nih.gov/pubmed/31631039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.09.033
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares